Korea FilingsFull brief — $39

Sam-A Pharm. Co. Ltd

삼아제약(주) · KOSDAQ: 009300 · Pharmaceuticals and medicinal chemicals

Key facts

Korean name
삼아제약(주)
Market / ticker
KOSDAQ · 009300
Industry
Pharmaceuticals and medicinal chemicals
Established
1973-10-04
Fiscal year ends
December
Website
www.samapharm.co.kr
DART corp code
00126788
Latest revenue
₩77.8B (FY2025)

Items worth checking

No rule-based items found in the latest annual report or the last 12 months of filings. This is a limited automated check, not a clean bill of health.

Financial summary

KRWFY2023FY2024FY2025
Revenue₩97.2B₩95.6B₩77.8B
Operating income₩23.5B₩24.5B₩11.0B
Net income₩21.4B₩22.1B₩12.9B
Total assets₩231.3B₩248.7B₩247.0B
Total liabilities₩30.8B₩28.8B₩18.9B
Total equity₩200.5B₩220.0B₩228.1B
Share capital₩6.4B₩6.4B₩6.4B

Consolidated statements · FY2025 operating margin 14.1% · liabilities to equity 8% · Annual report FY2025 (Korean original)

Auditor opinions

PeriodAuditorOpinion
Term 53 (current)한영회계법인Unqualified
Term 52 (prior)한영회계법인Unqualified
Term 51 (two years prior)삼일회계법인Unqualified

Largest shareholder history

No change history reported in the latest annual report.

Recent filings

DateFilingOriginal
2026-08-13Half-year report (2026.06)DART
2026-05-14Quarterly report (2026.03)DART
2026-04-22Amended: Annual report (2025.12)DART
2026-03-30Amended: Annual general meeting resultsDART
2026-03-27Corporate value-up plan (voluntary)DART
2026-03-27Annual general meeting resultsDART
2026-03-20Annual report (2025.12)DART
2026-03-19Audit report submittedDART
2026-03-11Proxy solicitation reference documentDART
2026-03-11Notice of shareholders meetingDART
2026-02-26Reason for holding meeting on peak AGM dateDART
2026-02-26Resolution to convene shareholders meetingDART
2026-02-26Cash / in-kind dividend decisionDART
2026-02-26Revenue or profit structure changed materiallyDART
2025-11-13Quarterly report (2025.09)DART
Full brief on Sam-A Pharm. Co. Ltd — $39 Get the full brief

For business customers. EU companies: enter your VAT number at checkout and no VAT is charged (reverse charge).

Other Korean companies in Pharmaceuticals and medicinal chemicals

Data generated 2026-09-16 from OpenDART.

This page summarizes public filings from DART, the official electronic disclosure system of Korea. It is not investment, credit or legal advice. Figures are shown in the currency the company reports in. Titles and labels are machine-translated and may contain errors — always check the linked original filing. Source: OpenDART, Financial Supervisory Service, Korea.